Valuation: Amarin Corporation plc

Market Cap 344M 303M 279M 261M 490M 32.43B 499M 3.36B 1.3B 16B 1.29B 1.26B 55.67B P/E 2026 *
-469x
P/E 2027 * 298x
Enterprise Value 170M 150M 138M 129M 242M 16.05B 247M 1.66B 643M 7.92B 639M 625M 27.54B EV / Sales 2026 *
0.93x
EV / Sales 2027 * 0.81x
Free-Float
89.38%
Yield 2026 *
-
Yield 2027 * -
1 day+2.76%
1 week+4.06%
Current month+13.25%
1 month+13.72%
3 months+13.41%
6 months+19.78%
Current year+17.59%
1 week 15.16
Extreme 15.16
17.25
1 month 13.6
Extreme 13.6
17.25
Current year 12.96
Extreme 12.96
17.31
1 year 12.96
Extreme 12.96
20.9
3 years 7.08
Extreme 7.08
29.7
5 years 7.08
Extreme 7.08
119.4
10 years 7.08
Extreme 7.08
522.4
Manager TitleAgeSince
Chief Executive Officer 63 04/06/2024
Director of Finance/CFO 42 23/10/2024
Compliance Officer 56 15/11/2023
Director TitleAgeSince
Director/Board Member 63 04/06/2024
Director/Board Member 43 28/02/2023
Director/Board Member 67 28/02/2023
Date Insider Type Main position Quantity % Market Cap.
04-18Fiscal year

Director

2,079 0.0005%
04-18Fiscal year

Director

2,079 0.0005%
04-18Fiscal year

Chairman

2,079 0.0005%
Change 5-day change 1-year change 3-year change Capi.($)
+2.76%+4.06%+2.34%-28.03% 344M
-7.92%-4.05%+53.28%+106.11% 52.88B
+8.55%+17.52%+72.65%+82.31% 50.98B
-0.45%-2.18%-14.16%-15.80% 22.81B
+1.28%+5.09%-2.30%+418.34% 22.43B
+2.65%+8.05%+29.57%-13.39% 17.01B
-0.15%+4.15%+27.79%-34.84% 15.91B
+2.98%+0.82%+15.64%+166.21% 13.29B
+5.94%+14.85%+134.05%+296.09% 13.58B
-0.71%+1.98%+78.88%+114.48% 11.75B
Average +1.49%+5.09%+39.77%+109.15% 22.1B
Weighted average by Cap. +0.86%+5.40%+45.47%+115.89%

Financials

2026 *2027 *
Net sales 182M 160M 148M 138M 259M 17.18B 264M 1.78B 689M 8.47B 684M 669M 29.48B 193M 170M 157M 147M 275M 18.18B 280M 1.88B 729M 8.97B 724M 709M 31.21B
Net income -15.02M -13.23M -12.2M -11.41M -21.38M -1.42B -21.78M -147M -56.79M -699M -56.4M -55.18M -2.43B 22.13M 19.48M 17.97M 16.81M 31.49M 2.09B 32.08M 216M 83.66M 1.03B 83.09M 81.29M 3.58B
Net Debt -174M -153M -141M -132M -247M -16.39B -252M -1.7B -657M -8.08B -653M -639M -28.13B -187M -165M -152M -142M -267M -17.67B -272M -1.83B -709M -8.72B -704M -689M -30.33B
Logo Amarin Corporation plc
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
Employees
80
Date Price Change Volume
24/06/26 US$16.41 +2.76% 125,513
23/06/26 US$15.97 +1.01% 124,817
22/06/26 US$15.81 -1.37% 166,093
18/06/26 US$16.03 +1.65% 87,091
17/06/26 US$15.77 +3.96% 81,442
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
16.41USD
Average target price
12.50USD
Spread / Average Target
-23.83%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMRN Stock